Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?
Colson AR, Morton A, Årdal C, Chalkidou K, Davies SC, Garrison LP, Jit M, Laxminarayan R, Megiddo I, Morel C, Nonvignon J, Outterson K, Rex JH, Sarker AR, Sculpher M, Woods B, Xiao Y.
Colson AR, et al. Among authors: woods b.
Value Health. 2021 Dec;24(12):1828-1834. doi: 10.1016/j.jval.2021.06.002. Epub 2021 Sep 20.
Value Health. 2021.
PMID: 34838281
Free article.
We argue that, to play their role more effectively, HTA agencies need to broaden their methodological tool kit, design and communicate their analysis to a wider set of users, and incorporate long-term policy goals, such as containing resistance, as part of their evaluation …
We argue that, to play their role more effectively, HTA agencies need to broaden their methodological tool kit, design and communicate their …